IPSC logo

Century Therapeutics (IPSC)

Profile

Full Name

Century Therapeutics, Inc.

Ticker Symbol

IPSC

Exchange

NASDAQ

Country

United States

IPO

June 18, 2021

Indexes

Not included

Employees

140

Key Details

Price

$0.50(+0.42%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$6.59M(+194.81% YoY)

Annual EPS

-$1.61(+30.00% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 3, 25 HC Wainwright & Co.
Buy
Mar 28, 25 Guggenheim
Buy
Mar 24, 25 Chardan Capital
Buy
Mar 21, 25 Guggenheim
Buy
Mar 20, 25 Piper Sandler
Overweight
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 22, 25 Guggenheim
Buy
Dec 30, 24 Piper Sandler
Overweight
Nov 7, 24 Chardan Capital
Buy
Nov 6, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Century Therapeutics?
  • Does Century Therapeutics pay dividends?
  • What sector is Century Therapeutics in?
  • What industry is Century Therapeutics in?
  • What country is Century Therapeutics based in?
  • When did Century Therapeutics go public?
  • Is Century Therapeutics in the S&P 500?
  • Is Century Therapeutics in the NASDAQ 100?
  • Is Century Therapeutics in the Dow Jones?
  • When was Century Therapeutics's last earnings report?
  • When does Century Therapeutics report earnings?
  • Should I buy Century Therapeutics stock now?

What is the ticker symbol for Century Therapeutics?

The ticker symbol for Century Therapeutics is NASDAQ:IPSC

Does Century Therapeutics pay dividends?

No, Century Therapeutics does not pay dividends

What sector is Century Therapeutics in?

Century Therapeutics is in the Healthcare sector

What industry is Century Therapeutics in?

Century Therapeutics is in the Biotechnology industry

What country is Century Therapeutics based in?

Century Therapeutics is headquartered in United States

When did Century Therapeutics go public?

Century Therapeutics's initial public offering (IPO) was on June 18, 2021

Is Century Therapeutics in the S&P 500?

No, Century Therapeutics is not included in the S&P 500 index

Is Century Therapeutics in the NASDAQ 100?

No, Century Therapeutics is not included in the NASDAQ 100 index

Is Century Therapeutics in the Dow Jones?

No, Century Therapeutics is not included in the Dow Jones index

When was Century Therapeutics's last earnings report?

Century Therapeutics's most recent earnings report was on Mar 19, 2025

When does Century Therapeutics report earnings?

The next expected earnings date for Century Therapeutics is May 9, 2025

Should I buy Century Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page